BIORA AB recently published research describing how BIORA`s lead product, EMDOGAIN®, initiates the regrowth of tooth-supporting tissues lost to periodontal disease. The articles detail the development of EMDOGAIN®, from initial research to preclinical and clinical studies demonstrating safety and efficacy in the treatment of periodontal disease.
BIORA AB recently published research describing how BIORA`s lead product, EMDOGAIN®, initiates the regrowth of tooth-supporting tissues lost to periodontal disease. The articles detail the development of EMDOGAIN®, from initial research to preclinical and clinical studies demonstrating safety and efficacy in the treatment of periodontal disease.
EMDOGAIN® is applied in a gel form directly onto the tooth-root surface during periodontal-flap surgery. Its key component, amelogenin, is a structural protein produced during normal tooth development.
For additional information, circle the number below or visit their Web Site at http://www.noonanrusso.com.
Whether you recently decided to make the leap or are still thinking it over, moving from server-based to cloud-based practice management software requires careful thought and ...
You've likely heard of “cloud-based” practice management software, but understanding it is another matter. Simply put, it involves accessing data via the internet, offering flexibility...
Discussing dental costs can be uncomfortable, but patient-led financing lets patients privately explore options that fit their budget, making it easier to accept necessary care...
Is your practice easy for patients to work with, or is there room for improvement? A recent report highlights that convenience, especially in digital support and access, often...
